AudioCure Pharma

AudioCure Pharma was founded in 2010 by Prof. Hans Rommelspacher, with the mission of developing new drugs to proect and restore the cellular key structures that are critical to the hearing process.

They are currently developing AC102 for the treatment of acute hearing disorders including acute hearing loss and acute tinnitus.

Clinical trials to be announced.